Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study. [electronic resource]
Producer: 20180723Description: 2017-2028 p. digitalISSN:- 1538-7836
- Adult
- Blood Coagulation -- drug effects
- Cross-Over Studies
- Drug Administration Schedule
- Factor Xa Inhibitors -- administration & dosage
- Germany
- Healthy Volunteers
- Humans
- Male
- Middle Aged
- Partial Thromboplastin Time
- Predictive Value of Tests
- Prothrombin Time
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Reproducibility of Results
- Rivaroxaban -- administration & dosage
- Thrombin -- metabolism
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.